Investigating bone health in patients with urinary stones
Bone Health in Patients with Urinary Stone Disease
This study is looking at how kidney stones might be connected to bone health, especially for people who could be at risk for weak bones or fractures, and it will explore whether certain medications for weak bones can help with both bone strength and preventing kidney stones from coming back.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11041034 on NIH RePORTER |
What this research studies
This research focuses on understanding the relationship between urinary stone disease and bone health. It aims to identify patients at high risk for osteoporosis or fractures and to explore how osteoporosis medications might affect both bone strength and urinary stone recurrence. Using advanced imaging techniques and biomarker analysis, the study will gather and analyze patient data to improve screening and management strategies for those affected by urinary stones. The ultimate goal is to enhance patient care and outcomes in this population.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with urinary stone disease who may also be at risk for osteoporosis or bone fractures.
Not a fit: Patients without urinary stone disease or those who do not have concerns regarding bone health may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better screening and treatment options for patients with urinary stone disease, potentially reducing their risk of fractures.
How similar studies have performed: Other research has indicated potential benefits of addressing bone health in patients with urinary conditions, but this specific approach using advanced imaging and biomarker analysis is relatively novel.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Ganesan, Calyani — Stanford University
- Study coordinator: Ganesan, Calyani
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.